Effects on quality of life
| QoL domain | AD | oPEP | ||||
| Baseline | 4 weeks | p-value | Baseline | 4 weeks | p-value | |
| Subjects n | 25 | 24 | ||||
| Respiratory symptoms | 67 (44–79.5) | 70 (50–79.5) | 0.732 | 65 (46–77) | 72 (48.8–80.3) | 0.139 |
| Physical functioning | 60 (20–83.5) | 67 (37–86.5) | 0.393 | 53.5 (21.8–93) | 60 (36.5–87) | 0.412 |
| Vitality | 44 (27.5–66.8) | 67 (44–67) | 0.027 | 44 (1–100) | 50 (33–67) | 0.231 |
| Role functioning | 73 (53–87) | 87 (56.5–93) | 0.073 | 70 (41.8–87) | 73 (48.5–80) | 0.970 |
| Emotional functioning | 83 (54–100) | 83 (62.5–100) | 0.611 | 79 (60.3–92) | 79 (67–98) | 0.690 |
| Social functioning | 50 (21–67) | 58 (37.5–76.5) | 0.042 | n=23 58 (42–83) | n=23 58 (44–75) | 0.919 |
| Treatment burden | n=20 56 (33–78) | n=20 44 (33–64.3) | 0.085 | n=20 56 (35.8–75.3) | n=20 56 (33.3–67) | 0.458 |
| Health perceptions | 42 (33–67) | 58 (42–75) | 0.177 | 33 (25–58) | 42 (33–64.8) | 0.048 |
Scores presented as median (interquartile range) unless otherwise stated. Domains of the quality of life questionnaire for bronchiectasis (QoL-B) [21] were scored on a scale of 0 (worst) to 100 (best) and compared between baseline and end-of-study visits. QoL: quality of life; AD: autogenic drainage; oPEP: oscillating positive expiratory pressure. Values in bold represent p<0.05.